Biotech CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody March 4, 2025
Biotech Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA® March 4, 2025
Biotech BioRes Ruizhi BLC Implant System Showcased in China, Addressing Rising Demand for High-quality Implants March 3, 2025
Biotech Therapeutic Goods Administration decides not to register lecanemab in Australia March 3, 2025
Biotech POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS March 2, 2025
Biotech Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration March 1, 2025
Biotech A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore February 28, 2025
Biotech US FDA grants Priority Review to Sobi’s supplemental Biologics Licence Application (sBLA) for Gamifant® (emapalumab-lzsg) February 27, 2025
Search
Biotech
March 4, 2025
March 4, 2025
March 3, 2025
March 3, 2025
March 2, 2025
March 1, 2025
March 1, 2025
February 28, 2025
February 28, 2025
February 27, 2025
